The vote to reject a delay of the final ACTA vote was 420 Vs 255, followed by the rejection of ACTA by a vote of 478 to 39.
KEI Director James Love statement:
Continue Reading →
The below is a joint statement from EFF, Knowledge Ecology International, Public Knowledge, and Public Citizen.
Joint Statement of Civil Society Groups on U.S. TPP Copyright Proposal
Continue Reading →
Deputy USPTO Director Teresa Stanek Rea has issued a retraction of her statement regarding Administration support for 12 years of exclusive rights in test data for biologic drugs, and moderated somewhat her statement on the India compulsory license for Nexavar. USTR also issued a statement on the issue of biologic test data in response to Rea’s earlier comments.
Continue Reading →
Hearings on intellectual property rights, 112th Congress
House of Representatives
- April 26, 2012. Hearing on: “International Patent Issues: Promoting a Level Playing Field for American Industry Abroad” Subcommittee on Intellectual Property, Competition and the Internet. http://judiciary.edgeboss.net/wmedia/judiciary/ip/ip04262012.wvx
- May 26, 2012. Hearing on: Implementation of the Leahy-Smith America Invents Act, Full Judiciary Committee Hearing. http://judiciary.edgeboss.net/wmedia/judiciary/full/fullcomm05162012.wvx
Continue Reading →
On June 27, 2012, Teresa Stanek Rea, the Deputy Under Secretary of Commerce for Intellectual Property and the Deputy Director of the United States Patent and Trademark Office (USPTO), testified at a hearing on: “International IP Enforcement: Protecting Patents, Trade Secrets and Market Access”, before the US House of Representatives, Judicary Committee, Subcommittee on Intellectual Property, Competition, and the Continue Reading →
